Analysis of tizoxanide, active metabolite of nitazoxanide, in rat brain tissue and plasma by UHPLC–MS/MS. (2nd December 2019)

• Record Type: Journal Article
• Authors: Guo, Sixun; Li, Fang; Wang, Bin; Zhao, Yilei; Wang, Xiaoxiong; Wei, Hua; Yu, Kaijiang; Hai, Xin
• Is Part Of: Biomedical chromatography. Volume 34:Number 2(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2019-12-02
• Subjects: brain tissue -- nitazoxanide -- tizoxanide -- UHPLC–MS/MS; Chromatographic analysis -- Periodicals; Biology -- Periodicals; Medicine -- Periodicals; Biology -- Periodicals; Chromatography -- methods -- Periodicals; Medicine -- Periodicals; 543.089
• DOI: 10.1002/bmc.4716
• Languages: English
• ISSNs: 0269-3879

Abstract

Abstract: Tizoxanide, the active metabolite of nitazoxanide, has recently been reported as an effective agent for the treatment of glioma. As there had been no report about the analysis of tizoxanide in brain tissue, we established extraction and UHPLC–MS/MS methods to quantify tizoxanide in rat brain and plasma to evaluate the brain‐to‐plasma ratio of tizoxanide. The biological samples were mainly prepared by acetonitrile and the separation was performed on a Waters XBridge® BEH C18 column. The mobile phase was composed of water mixed with 10 mm ammonium formate (pH 3.0) and acetonitrile according a gradient volume. Tizoxanide and topiramate (internal standard) were monitored utilizing negative electron spray ionization in multiple reaction monitoring mode. The methods were validated to be precise and accurate within the dynamic range of 5–1000 ng/mL and 0.2–50 ng/g for plasma and brain tissue samples, respectively. The lower limit of quantitation of the method was 0.2 ng/g, which was far more sensitive than all existing methods to quantify tizoxanide in biological samples. Application performed on rats exhibited that the brain‐to‐plasma ratio of tizoxanide ranged from 3.16 to 26.86% in 1 h after administration of 10 mg/kg nitazoxanide.